Association of socioeconomic status with adherence to oral agents in patients with multiple myeloma.

被引：0
|
作者：
Rutter, Wilbur
Prakash, Shivaani
Cavers, William
Avalos-Reyes, Elisea
Johnson, Kjel Andrew
Bernal-Mizrachi, Leon
机构：
[1] CVS Hlth, Lincoln, RI USA
[2] Emory Univ, Winship Canc Inst, Sch Med, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8023
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CZDez: An oral chemotherapeutic regimen for the treatment of multiple myeloma.
    Moreton, P
    Morgan, GJ
    Cooke, G
    Hillmen, P
    Child, T
    BLOOD, 2001, 98 (11) : 310B - 310B
  • [22] Improving time to initiation of bone modifying agents in patients with newly diagnosed multiple myeloma.
    Rosko, Nathaniel
    Lee, Sarah
    Samaras, Christy Joy
    Mejia, Alex V.
    Anwer, Faiz
    Faiman, Beth
    Mathur, Saveta
    Hamilton, Kimberly
    Reed, Janice
    Karam, Mary Ann
    Valent, Jason Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Socioeconomic status is independently associated with overall survival in patients with multiple myeloma
    Fiala, Mark A.
    Finney, Joseph D.
    Liu, Jingxia
    Stockerl-Goldstein, Keith E.
    Tomasson, Michael H.
    Vij, Ravi
    Wildes, Tanya M.
    LEUKEMIA & LYMPHOMA, 2015, 56 (09) : 2643 - 2649
  • [24] Plasma cobalamin levels of patients with multiple myeloma.
    Hine, RJ
    Zangari, M
    FASEB JOURNAL, 2002, 16 (05): : A747 - A747
  • [25] Evaluation of prognostic factors in patients with multiple myeloma.
    Hungria, VTM
    Gomez, M
    Moraes, JC
    Barros, JC
    Chiattone, CS
    BLOOD, 1995, 86 (10) : 3329 - 3329
  • [26] PTEN gene deletions in patients with multiple myeloma.
    Qi, XY
    Stewart, AK
    Chang, H
    BLOOD, 2004, 104 (11) : 304B - 304B
  • [27] NEW ERA IN MULTIPLE MYELOMA. CONSEQUENCES OF THE ARRIVAL OF NEW AGENTS
    Sobejano Fuertes, E.
    Gonzalez, V
    Higuero, V
    Garcia-Sanz, R.
    Presa, D.
    Azibeiro, R.
    Fonseca, M.
    Rey, B.
    Puig, N.
    Gutierrez, N.
    Leoz, P.
    Labrador, J.
    Aguilera, C.
    Escalante, F.
    Alonso Jose, M.
    Lopez, R.
    Garcia-Mateo, A.
    Garcia de Coca, A.
    Hernandez, R.
    Barez, A.
    Redondo, E.
    Mateos, M., V
    HAEMATOLOGICA, 2019, 104 : 20 - 21
  • [28] Drug resource use and costs for novel agents in multiple myeloma.
    Binder, Gary
    Harwin, William N.
    Stemkowski, Stephen
    Zhou, Yunping
    Khan, Zeba M.
    Nourbakhsh, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Albuminuria and alphal microglobulinuria in patients with multiple myeloma.
    Garcia, SSM
    Bottini, PV
    Metze, IL
    Alves, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 679A - 679A
  • [30] Human herpesvirus 8 in patients with multiple myeloma.
    Tisdale, JF
    Stewart, AK
    Dickstein, B
    Dube, ID
    Cappe, D
    Dunbar, CE
    Brown, KE
    BLOOD, 1997, 90 (10) : 2614 - 2614
12345